Search results for "india"
Article
Setting Standards for Biotech Therapeutics in India
35-40
The past decade has seen considerable growth in the Indian pharmaceutical industry. India has emerged as a key supplier of high quality and affordable medicines not only to the developing w…
Article
Drug Discovery and Development in India
Over the past few years, Indian pharmaceutical companies have been attempting to re-orientate their efforts toward developing new innovative medicines, Ang Wei Zheng, analyst of Business Monitor Inter…
Article
Report from India
(Dmitry Rukhlenko/Getty Images)
On July 1, India's new Drug Pricing Control Order (DPCO) 2013 replaced the 1995 version. Under this new regime, the National Pharmaceutical Pricing Pol…
Article
Biomanufacturing Outsourcing Globalization Continues
Top outsourcing destinations
Offshoring for biologics has been generally equated with emerging hubs in Asia, especially Singapore, China, India, or Korea. This trend is changing, as domestic CMOs …
Article
Bureaucratic Roadblocks Threaten Biopharma Growth
Patent uncertainty abroad
The Biotechnology Industry Organization (BIO) is concerned over a series of patent revocations including a decision by India’s Supreme Court to deny patent protection fo…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
Brazil, Mexico, Venezuela, Columbia, and India now have at least draft, if not established, regulations for biosimilar approval in place. Russia is also developing an approval pathway, as are countrie…
Article
Global Expansion Shapes Drug Oversight
Challenges in India and China
At the MHRA meeting, Hamburg commented on her visit to India in February and FDA efforts to expand inspections and develop stronger ties with local regulatory autho…
Article
Outsourcing Trends in Biopharmaceutical Manufacturing
Over the past decade, BioPlan has found that developing regions, including China, India, and Brazil, as well as the substantial investments in technologies that improve productivity and efficiency are…
Article
The Good and Bad of Biosimilars
…g from both established companies and new players, including companies in emerging markets, such as India. A number of companies have found success in the biosimilars market, having experience in bio…
Article
Establishment of New Modern Plasma Fractionation Facilities in Asia
In India, Reliance Life Sciences manufactures a range of plasma products for the subcontinent and Sri Lanka. Meanwhile, Intas and Hemarus have smaller fractionation capacities. In Korea, three compani…